Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Micron Technology Inc. €158.86 €169.48
Autozone Inc. €3,525.0 €3,711.1
NVIDIA Corp. €159.00 €173.74
Security Price Target price
Geratherm Medical AG €5.88 -
General Mills Inc. €43.80 €53.90
Critical Metals Ltd. €8.85 €1.00

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

Biotech 2025
Total
€133,143
Cash
€4,140.9
Performance (%)
33.143%

Pros and Cons of these stocks (New Predictions)

Oracle Corp.

WKN: 871460 / Symbol: ORCL / Name: Oracle / Stock / Software & IT Services / Large Cap /

Pros
2
Very small cyclical dependencies
3
High dividend yield expected
2
Very positive Cash Flow expected
Cons
Shop Apotheke Europe NV

WKN: A2AR94 / Name: Shop Apotheke Europe / Stock / Software & IT Services / Mid Cap /

Pros
4
High dividend yield expected
7
Well known brand
7
Very Future proof/growth oriented business model
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Discovery Communications C €22.42 5.110%
Advanced Micro Devices Inc. €182.62 5.010%
Centene Corp. €33.43 4.000%
Lam Research Corp. €7,371.0 3.990%
Westrock Co €47.53 3.930%
Security Price Change(%) (%)
Ford Motor Co. €10.15 -6.520%
Seagate Technology.Holdings plc €195.30 -5.830%
Expedia Inc. €181.40 -5.110%
Borgwarner Inc. €36.02 -5.060%
Oracle Corp. €237.15 -4.780%

Courses

Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.
Get started on the stock market in these easy steps
This course is directed at beginners who want to get started on the stock market.

Things you will learn:
  •  What is a stock
  •  What is a fund
  •  What is an ETF
  •  How to open a depot
  •  How to manage a depot that will regularly beat managed funds
  •  Why you mostly need patience to succeed on the stock market

Predictions

Principal Financial Group

Start price
Target price
Perf. (%)
€71.50
17:45
€68.38
07.10.26
-
06.10.25

buy
Metlife Inc.

Start price
Target price
Perf. (%)
€71.03
17:45
€82.92
07.10.26
-
15:47

buy
Lincoln National

Start price
Target price
Perf. (%)
€34.94
17:45
€45.30
07.10.26
-
15:38

buy
Kinsale Capital Group Inc

Start price
Target price
Perf. (%)
€406.30
17:45
€427.40
07.10.26
0.00%
17:45

Top News

News

Are Options Traders Betting on a Big Move in Badger Meter Stock?
Are Options Traders Betting on a Big Move in Badger Meter Stock?

Investors in Badger Meter, Inc. BMI need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 21, 2025 $130.00 Call had some of the highest

BFH Stock Trading at a Discount to Industry at 6.28X: Time to Hold?
BFH Stock Trading at a Discount to Industry at 6.28X: Time to Hold?

Bread Financial Holdings, Inc. BFH shares are trading at a discount compared with the Zacks Financial - Miscellaneous Services industry. Its forward price-to-earnings multiple of 6.28X is lower than

Will CorMedix's DefenCath Edge Last If Bigger Heparin Rivals Close In?: https://staticx-tuner.zacks.com/images/articles/main/c4/390.jpg
Will CorMedix's DefenCath Edge Last If Bigger Heparin Rivals Close In?

CorMedix’s CRMD lead drug, DefenCath (Taurolidine + Heparin), is currently its only marketed product that generates revenues for the company. The FDA approved CorMedix’s DefenCath in late 2023 as

5 Reasons That Make Equinix Stock a Solid Portfolio Pick Now
5 Reasons That Make Equinix Stock a Solid Portfolio Pick Now

In a world where digital transformation is paramount, Equinix EQIX continues to prove itself to be a pivotal player in the global digital infrastructure landscape. Analysts also seem bullish on this

Do Options Traders Know Something About Allegion Stock We Don't?
Do Options Traders Know Something About Allegion Stock We Don't?

Investors in Allegion plc ALLE need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $135.00 Put had some of the highest implied

Do AI Trees Grow to the Sky?: https://staticx-tuner.zacks.com/images/articles/main/5a/126353.webp
Do AI Trees Grow to the Sky?

Tuesday, October 7, 2025Despite flying blind into an economy that looked to be destabilizing somewhat prior to the federal government shutdown, major market indexes since the first of the month are

Sprouts Farmers' Digital Shift Fuels Strong Customer Engagement
Sprouts Farmers' Digital Shift Fuels Strong Customer Engagement

Sprouts Farmers Market, Inc.’s SFM increased focus on digital transformation is driving stronger customer engagement and higher spending among loyal customers. The impact was evident in the second

JPM Stock Before Q3 Earnings: Should You Buy Now or Wait for Results?
JPM Stock Before Q3 Earnings: Should You Buy Now or Wait for Results?

JPMorgan JPM is scheduled to announce third-quarter 2025 earnings on Oct. 14. As the largest American bank, its earnings are closely watched for insights into the financial sector, often serving as

MarketAxess' 3Q25 ADV Declines, Eurobond Gains Ease the Drop
MarketAxess' 3Q25 ADV Declines, Eurobond Gains Ease the Drop

MarketAxess Holdings Inc. MKTX recently announced that in the third quarter of 2025, it achieved a total trading average daily volume (ADV) of $38.8 billion, a 4% year-over-year decrease. Declines

Contest

Compete in Catch the Monkey ...

... and win a prize!

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren